Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Yole Développement Announces New Technology & Market Analysis

Published: Monday, June 10, 2013
Last Updated: Sunday, June 09, 2013
Bookmark and Share
“Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets, a new report from Yole Développement.

Yole Développement has announced its new technology & market analysis: Microfluidic applications in the pharmaceutical, life sciences, in vitro diagnostic and medical device markets.

With this report, Yole Développement proposes users to learn more about the microfluidic devices market. “The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018”, announces Benjamin Roussel, Technology & Market Analyst, Microfluidics & Medical Technologies at Yole Développement.

According to him, “This impressive 27% growth will be fueled mainly by pharmaceutical research and point-of-care applications”.

The microfluidic device market is expected to reach $5.7B by 2018!
Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.

By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies.

Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010 - 2012 and provides forecasts for 2013 - 2018.

Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production.

These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content.

The distinction between the microfluidic device market (first-level package device) and the microfluidic technology-based test market has also been calculated.

Discover the microfluidic market’s complex organization, broken down in nine segments
Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application.

For example, the added value of microfluidic devices in point-of-care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility.

Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.

This report provides a market segmentation covering the following applications: general dispensing - drug delivery - accurate dispensing - analytical devices - clinical and veterinary diagnostics - point-of-care testing - industrial and environmental testing - pharmaceutical and life science - microreaction technology.

Each application is presented with market data, trends/drivers, key players and technologies used.

Recent changes in the material mix provide new opportunities for polymer and silicon
Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics.

Whereas polymer is becoming the reference substrate for point-of-care applications, glass is still the main substrate for analytical devices. The penetration rate of each substrate vs. Microfluidic application is presented in this report.

Recently, the material mix has changed due to:
• The need to reduce device cost for some applications (i.e. switching from glass to polymer)
• The need to add new on-chip functions linked to emerging applications (i.e. growth of silicon use)

Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players.

This report provides an analysis of these new opportunities, in line with material mix changes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Yole Développement Announces Foundation of BLUMORPHO
BLUMORPHO will create value from innovation.
Tuesday, February 17, 2015
Evaluate the Manufacturing Cost of MEMS Devices with Cost Analysis Tool
Yole Développement and its partner, System Plus Consulting propose a relevant tool to analysis MEMS manufacturing cost.
Thursday, September 10, 2009
Yole Announces LifeScienceIC Report and Business Convention at EuroBIO 2006
The Business Convention Innovation Dating "When Micro & Nanotechnologies meet Life Sciences Industry", on Friday October 27th.
Monday, October 02, 2006
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos